Maravai LifeSciences
MRVI
#5247
Rank
HK$12.42 B
Marketcap
HK$33.68
Share price
1.90%
Change (1 day)
98.27%
Change (1 year)

Revenue for Maravai LifeSciences (MRVI)

Revenue in 2025 (TTM): HK$1.44 Billion

According to Maravai LifeSciences 's latest financial reports the company's current revenue (TTM ) is HK$1.45 Billion. a decrease over the revenue in the year 2024 that were of HK$2.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Maravai LifeSciences from 2020 to 2025

Annual revenue

Year Revenue Change
2025 HK$1.44 B-28.14%
2024 HK$2.01 B-10.89%
2023 HK$2.25 B-67.29%
2022 HK$6.89 B10.7%
2021 HK$6.23 B182.97%
2020 HK$2.20 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
HK$1.12 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
HK$0.17 B-88.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
HK$8.48 B 483.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
HK$5.28 B 263.09% Jersey